Tscan Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Tscan Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Tscan Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tscan Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $10M | 1.8M | 5.83 |
| 2023-09-30 | $4.5M | 1.8M | 2.56 |
| 2023-06-30 | $3.4M | 1.4M | 2.50 |
| 2023-03-31 | $623k | 297k | 2.10 |
| 2022-12-31 | $412k | 266k | 1.55 |
| 2022-06-30 | $711k | 226k | 3.14 |
| 2022-03-31 | $636k | 227k | 2.80 |
| 2021-09-30 | $3.7M | 445k | 8.34 |